Patent · US Active

Vesicular stomatitis vectors encoding Crimean-Congo hemorrhagic fever antigen

US11274282B2 · kind B2 · utility

0Cited by
1References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 15, 2020
Grant dateMar 15, 2022
Priority date
Expiry dateSep 30, 2040

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/26
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Certain embodiments are directed generally to compositions and methods related to recombinant vesicular stomatitis virus vectors (ΔGrVSV) encoding Crimean-Congo Hemorrhagic Fever glycoprotein precursor (CCHFV-GPC) and forming a recombinant vesicular stomatitis virus vector encoding Crimean-Congo Hemorrhagic Fever glycoprotein precursor (ΔGrVSV-CCHFV-GPC).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.